StimateActive Ingredient(s): Desmopressin
FDA Approved: * March 7, 1994
Pharm Company: * ZLB BEHRING
Desmopressin, sold under the trade name DDAVP among others, is a medication used to treat diabetes insipidus, bedwetting, hemophilia A, von Willebrand disease, and high blood urea levels. In hemophilia A and von Willebrand disease, it should only be used for mild to moderate cases. It may be given in the nose, by injection into a vein, by mouth, or under the tongue. Common side effects include headaches, diarrhea, and low blood sodium.&... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.